U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H5N3O2
Molecular Weight 163.1335
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 7-NITROINDAZOLE

SMILES

[O-][N+](=O)C1=CC=CC2=C1NN=C2

InChI

InChIKey=PQCAUHUKTBHUSA-UHFFFAOYSA-N
InChI=1S/C7H5N3O2/c11-10(12)6-3-1-2-5-4-8-9-7(5)6/h1-4H,(H,8,9)

HIDE SMILES / InChI

Molecular Formula C7H5N3O2
Molecular Weight 163.1335
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

7-Nitroindazole (aka 7-NI) is an experimental small molecule that acts as a selective inhibitor of neuronal nitric oxide synthase, which normally converts arginine to citrulline and nitric oxide (NO) in neuronal tissues. It has been investigated for potential use as an anti-nociceptive compound and as a means of mitigating neurodegenerative damage.

CNS Activity

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
0.9 µM [IC50]
3.67 null [pEC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Primary
Unknown
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
7-Nitroindazole was administered to mice by intraperitoneal injection in a dose range of 10 - 50 mg/kg. 7-Nitroindazole demonstrated anti-nociceptive effects in the late phase of the formalin-induced hind-paw licking and acetic acid-induced abdominal constriction assays; the ED50 for each assay was 27.5 and 22.5 mg/kg respectively. Maximum antinociceptive activity and NOS inhibition were detected 18-30 min following i.p. administration.
Route of Administration: Intraperitoneal
In Vitro Use Guide
Rabbit aortic rings (with and without endothelium) were mounted for isometric tensile recording in an organ bath containing Krebs solution at 37 deg-C in an atmosphere of 5% CO2. The tissue was placed under an initial tension of 2 g and left to equilibrate for 30 - 45 minutes. Aortic rings were then precontracted with 0.2 micro-M phenylephrine. Once stable contractions were observed, cumulative concentration-effect curves were determined for 7-Nitroindazole (1 micro-M to 1 mM). Concentration-effect curves to 7-Nitroindazole were also determined in rabbit aorta after incubation with the nitric oxide synthase inhibitor L-N^G-nitro arginine p-nitroanilide (50 micro-M) for 60 minutes. The failure of acetylcholine (2 micro-M) to induce relaxation in rabbit aorta was taken as an indication of the absence of a functional endothelium. 7-Nitroindazole caused concentration-dependent relaxations in rabbit aorta with a -log EC50 of 3.67. The relaxant response to 7-Nitroindazole was not significantly different in aortic rings with or without a functional endothelium, or after pretreatment with L-N^G-nitro arginine p-nitroanilide.
Substance Class Chemical
Record UNII
UX0N37CMVH
Record Status Validated (UNII)
Record Version